Ignite Creation Date:
2024-05-06 @ 12:40 AM
Last Modification Date:
2024-10-26 @ 10:53 AM
Study NCT ID:
NCT01636947
Status:
COMPLETED
Last Update Posted:
2018-09-25
First Post:
2012-07-05
Brief Title:
A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy Non-doxorubicin Hydrochloride Adriamycin and Cyclophosphamide Regimens MK-0869-225 KMEC
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2014-08-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-08-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-05
First Submit QC Date:
July 9 2012
Study First Post Date:
2012-07-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2015-07-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-27
Last Update Post Date:
2018-09-25
Last Update Post Date Type:
ACTUAL